Seroquel XR in the Long Term Treatment of Schizophrenia

CompletedOBSERVATIONAL
Enrollment

1,606

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Relapse in Schizophrenia
Trial Locations (61)

Unknown

Research Site, Baja

Research Site, Balassagyarmat

Research Site, Barcs

Research Site, Berettyóújfalu

Research Site, Budapest

Research Site, Cegléd

Research Site, Csongrád

Research Site, Debrecen

Research Site, Dombóvár

Research Site, Dunaújváros

Research Site, Eger

Research Site, Emőd

Research Site, Esztergom

Research Site, Érd

Research Site, Gödöllő

Research Site, Gyöngyös

Research Site, Győr

Research Site, Gyula

Research Site, Hajdusamson-Martinka

Research Site, Hajdúszoboszló

Research Site, Heves

Research Site, Jánoshalma

Research Site, Jászberény

Research Site, Kalocsa

Research Site, Karcag

Research Site, Kecskemét

Research Site, Kétegyháza

Research Site, Kiskunhalas

Research Site, Kiskunmajsa

Research Site, Kistarcsa

Research Site, Kistokaj

Research Site, Komárom

Research Site, Kozármisleny

Research Site, Miskolc

Research Site, Nagyatád

Research Site, Nagykanizsa

Research Site, Nagykálló

Research Site, Nagykőrös

Research Site, Ny�regyhaza

Research Site, Pécs

Research Site, Pomáz

Research Site, Salgótarján

Research Site, Sátoraljaújhely

Research Site, Soltvadkert

Research Site, Sopron

Research Site, Szeged

Research Site, Szeghalom

Research Site, Szekszárd

Research Site, Szentendre

Research Site, Szentes

Research Site, Székesfehérvár

Research Site, Szigetszentmiklós

Research Site, Szigetvár

Research Site, Szolnok

Research Site, Szombathely

Research Site, Tata

Research Site, Tatabánya

Research Site, Tószeg

Research Site, Vác

Research Site, Veszprém

Research Site, Zalegerszeg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY